Molander V, Bower H, Frisell T, Askling J, et al. Do newly approved drugs have a worse observed safety profile than once established? A study on time trends in risks of key safety outcomes with immunomodulatory drugs against rheumatoid arthritis. Ann Rheum Dis 2025 Feb 17:S0003-4967(25)00075-5. doi: 10.1016/j.ard.2025.
PMID: 39966039